2-Pyrrolylethylamine

{{cs1 config|name-list-style=vanc|display-authors=6}}

{{Infobox drug

| drug_name =

| image = 2-Pyrrolylethylamine.svg

| width = 175px

| caption =

| pronounce =

| tradename =

| Drugs.com =

| MedlinePlus =

| licence_CA =

| licence_EU =

| DailyMedID =

| licence_US =

| pregnancy_AU =

| pregnancy_category =

| dependency_liability =

| addiction_liability =

| routes_of_administration =

| class =

| ATC_prefix =

| ATC_suffix =

| legal_status =

| bioavailability =

| protein_bound =

| metabolism =

| metabolites =

| onset =

| elimination_half-life =

| duration_of_action =

| excretion =

| CAS_number = 40808-62-6

| CAS_supplemental =

| PubChem = 13437360

| IUPHAR_ligand =

| DrugBank =

| ChemSpiderID = 13937234

| UNII =

| KEGG =

| ChEBI =

| ChEMBL =

| NIAID_ChemDB =

| PDB_ligand =

| synonyms = 2-(2-Pyrrolyl)ethylamine; NEA; 2-NEA

| IUPAC_name = 2-(1H-pyrrol-2-yl)ethanamine

| C=6 | H=10 | N=2

| SMILES = C1=CNC(=C1)CCN

| StdInChI = 1S/C6H10N2/c7-4-3-6-2-1-5-8-6/h1-2,5,8H,3-4,7H2

| StdInChIKey = IAZZNTYMXXEHHT-UHFFFAOYSA-N

}}

2-Pyrrolylethylamine (NEA, 2-NEA, or 2-(2-pyrrolyl)ethylamine) is a chemical compound of the arylalkylamine family.{{cite book | vauthors = Shulgin A, Manning T, Daley PF | chapter = #67. FEA | pages = 138–141 | chapter-url = https://archive.org/details/shulgin-index-vol-1/page/138/mode/1up | title = The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds | publisher = Transform Press | location = Berkeley, CA | volume = 1 | year = 2011 | isbn = 978-0-9630096-3-0 | oclc = 709667010 }}

It is related to other arylalkylamines as well as alkylamines including tryptamine (2-indolylethylamine), phenethylamine (2-phenylethylamine), 2-furylethylamine, thiopropamine (1-(2-thienyl)-2-aminopropane), and isocyclamine (cyclopentanylaminopropane), among others. Many of these compounds are monoamine releasing agents and/or reuptake inhibitors.

NEA is known to be pharmacologically active itself, for instance having histamine-like activity on the isolated guinea pig ileum and having effects on gastric acid secretion in dogs.

The compound was first described in the scientific literature by 1949.